pharmaceutical-market
Drug Compounders Sue US Fda Over Removal of Wegovy, Ozempic From Shortage List
FinanceAstraZeneca Boosts China Presence With FibroGen's Anemia Drug in $160 Million Deal
FinanceIrish Foreign Investment Chief Hopes Fall-Out From Trump Pharma Tariffs Limited
Top StoriesIn Weight Loss Battle, Novo and Lilly Face Growing Offensive From Licensed Copies
Grifols Shares Tumble as Brookfield Plans to Drop Takeover Plan
Date: November 27, 2024
MADRID (Reuters) -Canadian fund Brookfield is planning to drop its plan to take over Spain’s Grifols, two sources close to the matter said on Wednesday, sending shares in the pharmaceutical firm down 10%. Grifols shares were down 10% in early morning trading, having fallen as low as 12% while the blue-chip index IBEX 35 was...
FTSE 100 Subdued as Pharma Stocks Weigh
Date: November 15, 2024
(Reuters) – The main UK stock indexes were subdued on Friday, with losses in AstraZeneca and GSK weighing on the blue-chip FTSE 100, while data showed Britain’s economy contracted unexpectedly in September. Shares of drugmakers AstraZeneca dropped 2.4% and GSK dipped 3.2%, tracking losses in U.S. and European vaccine makers after U.S. President-elect Donald Trump...
Psoriasis Treatment Market Surges to Usd 48.09 Billion by 2031, Propelled by 8.7% Cagr – Verified Market Research®
Date: August 13, 2024
The Global Psoriasis Treatment Market Size is projected to grow at a CAGR of 8.7% from 2024 to 2031, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 24.67 Billion in 2024 and is expected to reach USD 48.09 Billion by the end of the forecast period. The psoriasis treatment market is driven...
Analysis-Europe Faces Long Wait for Weight-Loss Drugs as Governments Eye Costs
Date: July 10, 2023
Analysis-Europe faces long wait for weight-loss drugs as governments eye costs By Ludwig Burger and Andreas Rinke FRANKFURT (Reuters) – Novo Nordisk will start selling its hugely popular obesity drug Wegovy in Germany this month, its third European market, but only people who pay from their own pocket or have certain private health insurance plans...
Spain’s Grifols Names Current Chairman as Ceo, Ending Family Leadership
Date: May 8, 2023
Spain’s Grifols names current chairman as CEO, ending family leadership By Joan Faus BARCELONA (Reuters) -Grifols said on Monday its executive chairman Thomas Glanzmann will become its new chief executive with immediate effect, ending the founding family’s executive leadership at a time of turmoil within the Spanish pharmaceutical group. Glanzmann, who had served as the...
Generic Injectable Market Is Projected to Expand at a Robust 11% Cagr Through 2031
Date: March 13, 2023
Healthcare R&D spending in the United States increased by more than 33% between 2018 and 2020. Several investors in the United States are investing in research and development for the healthcare business, federal government, universities, and foundations. NEWARK, Del: As per FMI, the global Generic Injectable Market is estimated to reach US$ 85 Billion in 2021. Rising demand for...